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In spite of its incidence decreasing to 1% nowadays, prosthesis-related infection remains a research, diagnostic,
therapeutic and cost-related problem. It can be defined as a presence of bacteria in the artificial joint space, which
is significantly associated with evident laboratory and/or tissue markers, and clinical signs of running infection. We
believe that the more precise understanding of pathogenesis, the more effective preventative and therapeutic
measures, and the lower infection rate. The implants are colonized by airborne, skin-, and/ or surgeon-related
bacteria during surgery despite being operated in closely respected operating regime. Some prosthetic characteris-
tics  are  advantageous  and  may  play  important  roles  in  the  process  of  bacterial  adherence.  After  successful
attachment on the biomaterial surface bacteria multiply and physiologically transform into a “biofilm” community,
making them much more resistant to antibiotic therapy and host immunity. Bacterial resistance is a complex
phenomenon influenced by intrinsic and extrinsic factors, including the cell configuration in the biofilm commu-
nity. So the cure of periprosthetic sepsis without removing of all foreign bodies and necrotic bone fragments is often
ineffective. Acute hematogenous sepsis is suggestive of a distortion of a previously aseptic joint space by invasion of
bacteria through the vessels.
operative  cultures  in  the  group  of  29  preoperatively
“aseptic” cases.57 The endeavour of this “research party”
has  culminated  with  the  idea  that  aseptic  failure  of
artificial joints is not as common as literature may re-
port. However, we cannot be definitely sure that posi-
tive  intraoperative  cultures  obtained  by  sophisticated
techniques from prosthetic surfaces are relevant to pros-
thesis-related infection because of the lack of the tissue
(Fig. 1) or systemic response.29, 50, 61, 71 On the other side
it is evident that colonization of prosthetic surfaces is
a key prerequisite for all acceptable natural histories of
prosthesis-related infection.
Coventry distinguished three basic clinical types of
periprosthetic infection: acute postoperative, late chro-
nic, and acute hematogenous.13  The acute postopera-
tive type develops within three months after the surgery.
With  the  chronic  type,  delayed  sepsis  occurs  3  to
24 months after the surgery. The last type (AHI) can be
expressed at any time postoperatively, but it is necessary
to  demonstrate  causal  and  chronological  relations  to
running infection at any site in the host body. Tsukayama
et al. defined the fourth type of periprosthetic infection,
the so-called positive intraoperative culture referring to
asymptomatic bacterial colonization of prosthetic sur-
faces.74
Schmalzried et al. claimed that the majority of deep
hip arthroplasty infections were nonsurgical.69 We and
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INTRODUCTION
Total hip or knee arthroplasties belong to the most
common orthopaedic procedures. They are routine, ef-
fective, and successful. However, complications can oc-
cur and frustrate both the surgeon and his or her patient.
Deep infection is considered as one of the most serious
complications. It belongs to the large group of infec-
tions associated with indwelling medical devices. It can
be defined as the presence of bacteria in an artificial
joint space, which is significantly associated with evi-
dent  laboratory  and/or  tissue  markers,  and  clinical
signs of running infection.
According to the Swedish registry (1979–1998) there
were  7.2  %  hip  arthroplasties  revised  due  to  a  deep
sepsis.46 The revision rate of total hip arthroplasty due
to sepsis was 7 % in Finland in 1999 and 10.5 % in
Denmark between 1995 and 1998.44, 58 In general, cur-
rent rates of deep infection are estimated around 1 %
and between 1 % and 2 % for primary hip and knee
arthroplasties, respectively.20, 29, 41, 63, 65 The incidence of
infection following a revision hip arthroplasty has been
reported to range between 2 and 6 %. 20, 29
Some  investigators  have  suggested  that  the  real
number of deep sepsis is higher.51, 75 For instance, Pil-
náček and Bébrová strongly supported this opinion in
the  Czech  Republic  having  found  20  positive  intra-28
some other clinicians do not fully agree with this opi-
nion.7, 71 Actually, one-third of all septic failures due to
hematogenous spread seems to be a more realistic esti-
mate.
Successful treatment necessitates prompt and good
diagnosis, preferably based on a microbial analysis, and
adequate knowledge on the patient profile. At present,
both of them are subjects of controversies. McPherson
et al. developed a staging scheme for prosthesis-related
infection consisting of three main variables: infection
type, medical and immune status of a host, and local
status of the afflicted extremity.47 That was done with
hope that a more appropriate approach could be chosen
out of several therapeutic options, i.e. chronic antibiotic
suppression, debridement with retention of prosthesis,
reimplantation of new prosthesis, arthrodesis, amputa-
tion.  It  is  believed  that  each  of  the  clinical  types  of
periprosthetic infections has its therapeutic and prog-
nostic consequences.15, 16, 27, 30, 74
According to the literature, the failure rate of two-
stage revision knee arthroplasty is ranging between 0 %
and 23 %,48 except the study by Rand et al.,62 who re-
ported a failure rate of 44 % (4/9). A direct exchange of
infected hip arthroplasty (one-stage reimplantation) may
be successful in almost 83 % of cases,29, 37 whilst with
delayed reimplantation the rate of success may reach
94 %.29, 52, 82, 83
The management of infected arthroplasties has seri-
ous economic implications. Eg. in the United States, the
annual cost to treat 3,500 to 4,000 cases equalled 150 to
200 million USD.65 Sculco also argued that “early recog-
nition of infection and aggressive treatment by implant
removal  will  reduce  patient  risk  and  health  care  ex-
pense”.65
The most frequent prosthesis-related pathogens are
coagulase-negative  staphylococci  and  Staphylococcus
aureus,15 which  strongly  implicates  the  intraoperative
contamination scenario. From the pathogenetic point
of  view  it  is  possible  to  convert  Coventry-Tsukaya-
ma’s classification into two types only, namely the in-
fection  associated  with  intraoperative  colonization  of
prosthesis  (surgical  type),  and  a  rarer  form  of  post-
operative hematogenous colonization of the joint space
(Fig. 2). Having achieved firm adherence, the founder
bacteria form a biofilm colony by multiplying with specific
space organizing, and changing their physiology. The
biofilm, as a special form of bacterial life, is much more
resistant than the planktonic one, in practice being in-
curable without surgical removal. Consequently, it may
be alleged that more precise understanding of prosthe-
Fig. 1. a – a case of septic failure after TKA. Non-specific inflammatory tissue is present with budding capillaries,
PMNs, lymphocytes and fibroblasts. HE, 400×.
b – a  case  of  aseptic  failure  after  THA.  The  specimen  demonstrates  a  foreign  body  reaction  around
suspicious polyethylene particles (empty spaces). Multinucleated large cells and mononuclear histiocytes
with fumous slightly basophile cytoplasma are visible. HE, 400×.
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sis-related  infection  pathogenesis  could  improve  pre-
ventative  and  therapeutic  measures.  The  aim  of  the
present review is to make an outlook on the up-to date
knowledge on this issue.
CHARACTERISTICS OF COMMON
“ORTHOPAEDIC” BACTERIA
There  are  only  several  bacterial  species  that  play
a  role  in  prosthesis-related  infections.  A  majority  of
them is caused by Staphylococcus epidermidis and Sta-
phylococcus  aureus (Table  1).  Moreover,  vancomycin-
resistant enterococcus has recently become one of the
most serious pathogens.33, 68
Airborne bacteria present in operating rooms are
predominantly gram-positive microorganisms, and most
of them are derived from the skin, hair, and nose or oral
cavity of patients and operating room staff.28, 35, 64 The
skin at the operative site can be a source of bacteria in
spite of numerous contemporary antiseptic procedures.
The wound edges can be recolonized by bacteria within
30–180 minutes after the preparing of a patient.38, 64 In
addition,  the  modern  adhesive  draping  may  damage
a thin superficial layer of the skin, revealing deeper,
more resistant, bacteria.
Staphylococcus aureus belongs to the most virulent
bacteria.11 It is a common nosocomial pathogen which
can produce much more extracellular proteins than coa-
gulase-negative staphylococci.43, 79 Hence, the enzymes
and toxins are regarded as its main factor of virulence.39, 79
Coagulase-negative staphylococci include at least fif-
teen different species,2 and some of them are now recko-
ned  among  leading  pathogens  causing  periprosthetic
infections (Table 1). They form an extracellular matrix
named glycocalyx which is a fundamental of their sur-
vival strategy.
It is well-known that prosthetic surfaces can act as
a unique microbial substratum. The presence of poly-
ethylene seems to be much more attractive for Staphylo-
coccus epidermidis (Fig. 3) compared to Staphylococcus
aureus, while prosthetic metals are more suited for Sta-
Fig. 2. Two basic pathogenetic concepts of prosthesis-related infection.
a – surgical-related periprosthetic infection. Bacteria colonizing prosthetic or bone surfaces during sur-
gery. The whole process is influenced by quantitative and qualitative parameters of host and bacterial
organisms.
b – hematogenous periprosthetic infection. Bacteria invading into the sterile encapsulated joint space
through vessels (bacteremia).
Table 1.  A list of contributors supporting a hypothesis on the main role of staphylococci
in prosthesis-related infections.
Pathogenesis of prosthesis-related infection
  Authors  Site of infection  Number of cases/ 
pathogens 
Gram-positive 
organisms 
STAU  Coagulase-
negative STA 
Banit et al.
4  THA,TKA,SA  21/23  83%  43%  26% 
Backe et al.
3  TKA  12/11  82%  27%  27% 
Gambhir et al.
18  THA  301/?  87%  14%  55% 
Garvin et al.
19  THA, TKA  76/97  76%  19%  37% 
Goldman et al.
21  TKA  64/67  72%  22%  31% 
Hanssen, Osmon
30  THA  37/47  83%  28%  32% 
Holzer et al.
34  Megaprostheses  18/16  94%  25%  56% 
Segawa et al.
66  TKA  81/88  95%  73% 
Tsukayama et al.
74  THA  106/147  74%  22%  38% 
Ure et al.
76  THA  20/20  100%  25%  45% 
Whiteside
80  TKA  33/33  85%  15%  33% 
Younger et al.
82  THA  30/29  83%  21%  45% 
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phylococcus aureus.23, 25 Corrosion products from metal
surfaces can stabilize and strengthen their biofilm con-
struction.14, 23, 24 In addition, polymethylmethacrylate in-
creases the likelihood of infection by a combination of
favourable  surface  characteristics  and  a  negative  in-
fluence on chemotaxis, phagocytosis, and the biological
status of its surroundings.55, 56 It was also suggested that
Staphylococcus epidermidis might metabolize some es-
ters released from bone cement.23
The recent literature data estimate that almost 90 %
of staphylococci are penicillin resistant, and the resis-
tance to oxacillin is also increasing.2, 59 Unfortunately,
oxacillin resistance involves cross-resistance to all other
β -lactam antibiotics.2 Also, there are rare, but very se-
rious infections caused by streptococci (mainly group G)
and Gram-negative pathogens (Pseudomonas aeruginosa,
Proteus mirabilis, etc.). Furthemore, the role of anaero-
bic bacteria has been confirmed by several studies (e.g.
Propionibacterium  acnes  and  some  strain  of  pepto-
streptococci),16,  19,  57,  74 and  symbiotic  bacterial  species
also cooperate symbiotically in biofilm colonies causing
a polymicrobial prosthesis-related infection.
BACTERIAL ADHESION
It is believed that the key factor for the prosthesis-
related infection development is bacterial adherence on
the artificial joint surfaces. The chance for successful
bacterial colonisation of the joint space is influenced by
the prosthetic surface characteristics, occurrence of dead
bone fragments, and it is also dependent on host factors
(immune, non-immune). In addition, an important role
is played by the number of bacteria and their genetic
characteristics.14, 25, 26
Implants are covered with blood fractions (proteins,
plasma  macromolecules,  erythrocytes,  thrombocytes,
etc.) immediately after their insertion, referred to as
a conditioning film.77 Now it is hypothesized that con-
stituent bacteria are able to adhere on the conditioning
film, uncovered prostheses, or fragments of a dead bone
by help of a wide range of physical and chemical interac-
tions  (Fig.  4).  These  include  van  der  Waals’s  forces,
acid-base,  electrostatic  and  hydrophobic  interactions,
protein bindings, etc.14, 53, 54, 78 The surface characteristics
of the biomaterial also seem to be of importance, in-
cluding hydrophilicity, roughness, and surface charge.
The more hydrophilic and rougher, the better for bacte-
rial adhesion.10, 73 There are at least two phases of bacte-
rial attachment to distinguish: reversible (non-specific)
and irreversible (specific). The reversible adhesion re-
lies on the non specific physical and chemical characteris-
tics of the bacteria, as well as on the biomaterial and
surrounding joint fluid. The irreversible attachment is
mediated through more specific structures, for example
adhesin  receptors  expressed  on  the  bacteria  surfaces
(Fig. 4). They guarantee strong fixation of the bacteria
on the prosthetic surfaces covered with a conditioning
film.32, 49, 78 Götz and Peters suggested that the adherence
of  Staphylococcus  aureus  is  done  mainly  via  adhesin
structures bound on host protein-coated surfaces, while
the attachement of Staphylococcus epidermidis depends
largely on hydrophobic interactions.22
PROSTHETIC-RELATED  BIOFILM
DEVELOPMENT
Gristina  et  al.  proposed  an  elegant  pathogenetic
metaphor for the situation occurring shortly after the
insertion of implants: “the race for the surface”.25 Ac-
cording to this concept, the adhesion of bacteria and the
integration of biomaterials are similar processes. There-
fore, the final result (i.e. host coverage of the prosthetic
surface or succesful bacterial adhesion) depends prima-
rily on the velocity and configuration of these processes.
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Fig. 3. a – intraoperative view of a revised TKA with whitish coating (asterisk) on the polyethylene surface.
b–Staphylococcus  epidermidis  bacterial  colonies  on  the  polyethylene  surface  under  scanning  electron
microscope (SEM).31 Pathogenesis of prosthesis-related infection
Fig. 4. Bacterial biofilm development:
a – immediately  after  prosthesis  insertion  the  surface  is  covered  with  host  macromolecules  or  cells
(conditioning film).
b – conditioning film or pure prosthetic surface is colonized with bacteria of airborne-, surgical-, skin- or
hematogenous origin.
c – non-specific bacterial adhesion realized by van der Waals’s forces, acid-base, electrostatic and other
interactions.
d – irreversible locking to biomaterial done through multiple specific binding (mainly adhesin molecules).
Mature bacterial biofilm is encapsulated by host fibrous tissue.14, 24, 25, 7732
If the winner are bacteria, they can display their survival
strategy. More virulent pathogens expand through their
ellaboration of extracellular proteins (invasins),79 which
is in contrast to less virulent pathogens producing large
amounts of extracellular slime to embed and protect
bacterial cells. The glycocalyx can also stimulate mono-
cytes  to  secrete  PGE2  which  inhibits  proliferation  of
T-lymphocytes.72 The composition of slime remains con-
troversial;  however,  it  is  suggested  to  be  primarily
a complex polysaccharide substance.45 One may assume
that the formation of this structure, including fixation to
the biomaterial, may be a time-, energy- and material-
consuming process.
The biofilm consists of bacterial as well as host parts
that are created by fibrin, polymorphonuclear neutro-
phils, erythrocytes, histiocytes, fibroblasts and many oth-
ers constituents (Fig. 5).9 A fibrous capsule on the outer
surface of the biofilm can be considered as the interface
between host and bacterial organisms.9
Having observed the biofilm, Costerton et al.12 intro-
duced  a  metaphor  “it  looks  like  the  rocks  in  Alpine
streams” to describe it. According to Dunne14 the ma-
ture biofilm resembles an underwater coral reef with
a large number of channels and cavities to allow the
exchange of nutrients, waste, and signals. The bacteria
living  under  optimal  conditions  (nutrient,  waste,  gas,
space limitations) slow their growing rate, activate seve-
ral survival mechanisms or separate from the colony.14, 24
Under certain conditions a symbiotic relationship be-
tween more than one bacterial species may be advanta-
geous for the development of biofilm colonies.
POSSIBLE SCENARIOS
OF PROSTHESIS-RELATED INFECTION
The basic prerequisite for the development of pros-
thesis-related infection is successful bacterial colonisa-
tion of prosthetic and/or bone surfaces around the arti-
ficial joint space. Another important aspect is the host
body status, particularly the immune system and local
tissues. Impairment of the immunity due to prosthesis-
related23, 25, 55, 56 and/or patient-related factors (advanced
age, chronic inflammatory diseases, diabetes mellitus,
malnutrition,  immunosupressive  drugs,  chronic  renal
insufficiency,  etc.)27,  47  play  an  important  role  in
pathogenesis and onset of periprosthetic infections. The
number of “slightly” immunocompromised persons may
be increasing, among others as a result of a wide usage
of broad-spectrum antibiotics.
Once the bacteria have succesfully reached and adhe-
red on the artificial joint surfaces they begin to display
their programmes for self-preservation (transformation,
communication,  invasin  production,  biofilm  construc-
tion, etc.). They are perceived as a foreign organism in
the host body which triggers an immune response with
inflammation.  The  character  of  this  response  can  be
modified by a chronically immunoincompetent inflam-
matory zone surrounding artificial joints (e.g. exhausted
macrophages).23 Inside of this effective joint space there
is a huge number of prosthetic debris binding (exhaus-
ting) macrophages and other connective tissue cells in
the self-perpetuating particle disease.17, 31, 81 Several aut-
hors have found that adherent endotoxin is important
for a particle-induced osteolysis in vitro.5, 8, 36 Regardless
of the mechanism of periprosthetic osteolysis it is attrac-
tive  to  believe  that  osteolysis  may  maintain  immu-
noincompetency,  facilitate  expansion  of  the  biofilm
community, and/or development of hematogenous in-
fection.
One  can  speculate  at  least  four  scenarios  on  the
natural history of periprosthetic infection:
1. Prosthesis-related infection associated with intra-
operative inoculation of the joint space by virulent mi-
croorganisms causes rapid and early inflammation. This
form  of  infection  is  influenced  mainly  by  factors  of
Fig. 5. a – intraoperative view of a revised TKA after polyethylene insert retrieval (same case as in Fig. 3). Jelly-like
structures (asterisk) as observed on the tibial component surface.
b – blood elements, fibrin and a suspicious group of bacteria (asterisk) on the metal surface under SEM.
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pathogen  virulence,  whilst  the  role  of  host  immunity
seems to be secondary. Clinically there are clear local
signs  of  inflammation,  often  accompanied  by  several
systemic  symptoms.  Some  strains  of  Staphylococcus
aureus and other pathogens can produce aggressive ex-
tracellular proteins (toxic-shock syndrome toxin, etc.)
that  are  able  to  overcome  local  barriers  and  lead  to
global sepsis.
2. Prosthesis-related infection associated with strong
intraoperative or early postoperative contamination of
less  virulent  organisms  in  a  competent  host  can  be
occult for some time. The onset of infection is usually
manifested within two years after the surgery. The longer
the time to the onset, the lesser the virulence and/ or the
better host immunity. The “balance” between biofilm
community and the surrounding host tissue can be lost
gradually under the influence of functioning prosthesis,
local metabolic conditions, the tendency of bacteria to
expand, or dysfunction of the bone bed. Although it
remains unclear how long the occult bacterial infection
can be present without provocation of the host immu-
nity, it still seems that several years can be expected.51, 75
Another  interesting  question  may  arise:  What  is  the
cause of sudden biofilm recognition by the host immu-
nity? It could be due to pathogen-related conflicts (space,
nutrient  or  waste  limitations)  leading  to  the  biofilm
degradation. Further explanation can be based on sy-
nergy  between  bacterial  activity  and  running  particle
disease.  Biofilm  colonies  can  expand  simultaneously
with the expansion of the joint space associated with
particle disease (chronically immunoincompetent envi-
ronment, necrotic bone and soft tissues, etc.). On the
other hand, it is believed that the host reaction in con-
nection  with  antibiotic  prophylaxis  can  eliminate  the
majority of the less virulent contamination.
3. Prosthesis-related infection associated with small
intraoperative  contamination  of  less  virulent  micro-
organisms depends on the host status. The healthy host
body in concert with antibiotics is capable to eradicate
these microorganisms easily as this is its routine experi-
ence,  whilst  successful  colonization  is  in  progress  in
weakened patients. The more unstable the host immu-
nity, the quicker the clinical failure development. After
a “steady state” period mainly controlled by microbial
characteristics (i.e. recuperation, multiplication, grow-
ing, etc.) a phase of increasing symptoms may set out
including early loosening of implants.
4. The hematogenous prosthesis-related infection is
based  on  two  facts:  Each  of  us  can  have  bacteremia
under normal situations,40, 42 and microorganisms in the
bloodstream  are  able  to  leak  in  the  artificial  joint
space.6, 70 Therefore, there may be some risk for all the
patients  with  artificial  joint  replacement  to  develop
hematogenous deep periprosthetic sepsis.1 The diagno-
sis of hematogenous prosthesis-related infection must
be  based  on  the  pathogen  identity  and  time  period,
which can be often difficult to establish. On the other
hand, a finding of specific oral cavity flora in the hip or
knee is very suspicious for hematogenous seeding. It
should be emphasized that the concept of “race for the
surface” cannot explain adequately hematogenous bac-
terial seeding of the previously well functioning pros-
thesis. It is supposed that the artificial joint space is
seeded with significant bacteremia of dental,40,  42 uro-
genital, gastrointestinal or other origins.69 Today, there
is  also  increasing  knowledge  on  vascular  catheter-re-
lated infections60 that are now frequently encountered.
According to Sheretz, catheters may become colonized
by skin microflora within 8 days in 70 to 90% of cases.67
CLINICAL CONCLUSIONS
There are three crucial consequences resulting from
this review:
1. Preventative – it is impossible to eliminate a risk of
prosthesis-related  infections,  but  the  preventative
measures are strongly worth the effort.
2. Diagnostic – it is difficult to detect locally adherent
bacteria  by  routine  techniques  focused  mainly  on
planktonic bacteria.
3. Therapeutic – it is not possible to cure deep infec-
tion without implant removal and radical debride-
ment. Even if this is done, a danger of the septic
failure persists for a longer period of time.
Infection following total joint arthroplasty remains
a  serious  complication.  Virulent  pathogens  cause  an
acute form of infection with a consistent clinical picture
and laboratory findings. However, the majority of peri-
prosthetic infections are due to human skin saprophytes
of low virulence that are able to provoke only minimal
or  no  symptoms  for  some  time,  but  they  can  be  very
resistant to both the host immunity and antibiotics under
the  biofilm  “umbrella”.  Finally,  the  cultures  obtained
from different articular sites can be negative in spite of
evidently running infection. The incorrect diagnosis may
lead  to  inappropriate  surgical  procedures  associated
with a high risk of failure.
A list of abbreviations used:
PGE2 – Prostaglandin E2
PMNs – polymorphonuclear leukocytes
SA – shoulder arthroplasty
STA – staphylococci
STAU – Staphylococcus aureus
THA – total hip arthroplasty
TKA – total knee arthroplasty
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